Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)

China flag China · Delayed Price · Currency is CNY
26.18
+0.49 (1.91%)
May 19, 2026, 10:25 AM CST
Market Cap11.90B -8.3%
Revenue (ttm)5.91B -13.2%
Net Income-102.67M
EPS-0.22
Shares Out463.26M
PE Ration/a
Forward PE33.80
Dividend0.88 (3.26%)
Ex-Dividend DateFeb 5, 2026
Volume2,447,161
Average Volume5,990,533
Open25.53
Previous Close25.69
Day's Range25.53 - 26.30
52-Week Range24.85 - 40.68
Beta0.54
RSI35.13
Earnings DateApr 25, 2026

About SHA:603882

Guangzhou Kingmed Diagnostics Group Co., Ltd. operates as a third-party medical laboratory company. The company offers medical diagnostic information, clinical trial, lab, food and hygiene testing, health management, medical cold chain logistics, and scientific research services, as well as vitro diagnostics, healthcare big data, artificial intelligence, and forensic testing services. It operates 37 testing laboratories in mainland of China and Hong Kong. The company was founded in 2003 and is headquartered in Guangzhou, China. [Read more]

Sector Healthcare
Founded 2006
Employees 10,413
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603882
Full Company Profile

Financial Performance

In 2025, SHA:603882's revenue was 6.03 billion, a decrease of -16.12% compared to the previous year's 7.19 billion. Losses were -173.24 million, -54.56% less than in 2024.

Financial Statements